Loading
NASDAQHealthcareMedical - Distribution
Latest quote
$3.00
−$0.40 · -11.76%
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Regular session
$3.00
−$0.40 · -11.76%
Regular session · ET · Market data may be delayed.
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Day range
Current $3.00
52-week range
Current $3.00
Regular session · ET · Market data may be delayed.
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Day range
Current $3.00
52-week range
Current $3.00
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 23.34M USD | 18.13M USD | — | 32.78M USD |
| Cost of goods sold | 32.98M USD | 16.36M USD | — | 27.03M USD |
| Gross profit | −9.64M USD | 1.77M USD | — | 5.75M USD |
| Research and development | — | — | 375 USD | 1.4K USD |
| Selling, general, and administrative | 71.56M USD | 6.8M USD | 2.88M USD | 7.08M USD |
| Operating expenses | 71.56M USD | 7.91M USD | 2.88M USD | 9.17M USD |
| Interest expense | 4.58M USD | 831.47K USD | 15.08K USD | 287.18K USD |
| Depreciation and amortization | 3.21M USD | 1.11M USD | — | 2.09M USD |
| Operating income | −81.19M USD | −6.15M USD | −2.88M USD | −3.42M USD |
| Net income | −101.27M USD | −6.86M USD | −2.9M USD | −2.74M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | May 26, 2026 | 1:50 | — | — |
Effective May 26, 2026
1:50
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
